TY - JOUR
T1 - A practical approach to improve safety and management in chemotherapy units based on the PROCHE-Programme for optimisation of the chemotherapy network monitoring program
AU - Scotté, Florian
AU - Oudard, Stéphane
AU - Aboudagga, Hail
AU - Elaidi, Reza
AU - Bonan, Brigitte
PY - 2013/1/1
Y1 - 2013/1/1
N2 - The PROCHE (PRogramme d'Optimisation du circuit CHimiothErapie [Programme for optimisation of the chemotherapy network]) initiative is an innovative oncology-monitoring program designed to reduce patient waiting time and chemotherapy wastage, ultimately improving patient care. Laboratory test results and side effects data were collected for patients in the PROCHE monitoring program group 2 d prior to scheduled chemotherapy visits, allowing oncologists to confirm or delay each patient's chemotherapy. Data from 1037 patients entered in the PROCHE program were compared with 513 control patients, who had been treated according to previous typical hospital procedures. Results demonstrated significant reductions in mean hospital stay i.e. decreased it by 66 min and drug wastage decreased from 6% to 2% (95% CI (confidence interval) 0.21-0.59, P < 0.0001), and a significant increase in bed occupancy rates with the PROCHE initiative (all P < 0.0001 vs. controls). The incidence of pain and severity of fatigue were also reduced. In conclusion, the PROCHE initiative resulted in improved patient quality of care and reduced chemotherapy toxicities, and improved hospital and pharmacy productivity. These encouraging preliminary results warrant further study.
AB - The PROCHE (PRogramme d'Optimisation du circuit CHimiothErapie [Programme for optimisation of the chemotherapy network]) initiative is an innovative oncology-monitoring program designed to reduce patient waiting time and chemotherapy wastage, ultimately improving patient care. Laboratory test results and side effects data were collected for patients in the PROCHE monitoring program group 2 d prior to scheduled chemotherapy visits, allowing oncologists to confirm or delay each patient's chemotherapy. Data from 1037 patients entered in the PROCHE program were compared with 513 control patients, who had been treated according to previous typical hospital procedures. Results demonstrated significant reductions in mean hospital stay i.e. decreased it by 66 min and drug wastage decreased from 6% to 2% (95% CI (confidence interval) 0.21-0.59, P < 0.0001), and a significant increase in bed occupancy rates with the PROCHE initiative (all P < 0.0001 vs. controls). The incidence of pain and severity of fatigue were also reduced. In conclusion, the PROCHE initiative resulted in improved patient quality of care and reduced chemotherapy toxicities, and improved hospital and pharmacy productivity. These encouraging preliminary results warrant further study.
KW - Cancer
KW - Chemotherapy management
KW - Quality of care
KW - Supportive care
KW - Symptom management
UR - http://www.scopus.com/inward/record.url?scp=84872674681&partnerID=8YFLogxK
U2 - 10.1016/j.ejca.2012.08.025
DO - 10.1016/j.ejca.2012.08.025
M3 - Article
C2 - 23021062
AN - SCOPUS:84872674681
SN - 0959-8049
VL - 49
SP - 541
EP - 544
JO - European Journal of Cancer
JF - European Journal of Cancer
IS - 3
ER -